SWI Portfolio Rises by 10.7% – Driven by One Outlier and a Reverse Split

The cannabis industry entered 2026 amid expectations of recovery driven by potential federal reform, improving capital markets, and ongoing state legalization. Instead, the industry remains in a transition phase rather than a broad recovery by the end of June. The sector is characterized as stable but fragmented. The SWI Portfolio has increased by 10.7%, marking the third consecutive monthly rise. This was mainly driven by three companies, with one, Verano Holdings’s share price posting the largest increase, partly due to a 5-for-1 reverse split. Recent portfolio adjustments reflect this trend, emphasizing selective growth among key holdings.

·     Retail demand remains resilient despite broader consumer spending pressures.

·     New adult-use markets continue to expand in several states.

·     Large multi-state operators (MSOs) improved operating discipline through cost reductions and positive cash flow.

·     Institutional investors have shown renewed interest in the sector following regulatory clarity in several states.

·     Wholesale cannabis prices remain under pressure due to oversupply.

·     Limited access to traditional banking and capital continues to constrain growth.

·     Heavy taxation and regulatory complexity continue to compress margins.

·     Smaller independent cultivators and retailers remain under significant financial stress.

·     Overall industry growth continues, but profitability remains concentrated among the largest operators.

Established markets continue to mature, and markets such as California, Colorado, Oregon, and Michigan remain under pricing pressure due to excess production. Meanwhile, newer markets remain attractive because of a more balanced supply-demand dynamic

Strategic Implications for Pivoting Cannabis Companies

A pivot toward functional wellness is most compelling when companies diversify beyond cultivation and flower sales, build recognizable consumer brands, expand into national retail channels to reach more consumers, invest in research-backed formulations, focus on recurring consumer use, and reduce reliance on highly regulated dispensary markets.

Outlook for the Second Half of 2026

The cannabis industry is likely to remain a selective investment environment rather than one experiencing a broad recovery. Within that category, pivoting to non-intoxicating CBD products and carefully regulated low-dose, hemp-derived THC functional wellness offerings remain attractive consumer segments. Still, companies must adapt to a rapidly evolving federal and state regulatory landscape, including specific compliance requirements such as federal restrictions. The long-term opportunity remains significant, but execution and regulatory compliance are becoming increasingly important competitive differentiators

If you want to follow other companies that we cover with in-depth articles and research reports,

Go to www.stockwatchindex.com or our research site at www.swiresearch.com.

If this has been passed on to you, and you want to receive the SWI Newsletter,

go to stockwatchindex.com/sign-up